Eduovisual
Female Reproductive & Breast
Bartholin gland cyst and abscess: management
— Bartholin (greater vestibular) glands sit at 4 and 8 o'clock positions of the vaginal introitus, deep to the posterior labia majora
— Each gland drains via a ~2.5 cm duct into the vestibule; the duct, not the gland itself, is what typically obstructs
— Glands secrete mucus for vestibular lubrication; normally non-palpable
— Cyst: painless or mildly tender obstruction of the duct → sterile mucus accumulation
— Abscess: secondary bacterial infection of an obstructed duct; polymicrobial (gut/skin flora — E. coli, Staph, Strep, anaerobes); GC/CT possible but not the dominant pathogens in most US series
— Abscess forms over 2–4 days, often after a quiescent cyst
— Lifetime prevalence ~2% of women; peak incidence ages 20–30
— Postmenopausal new mass at the gland site → must rule out vulvar/Bartholin gland carcinoma (rare but classic Step 3 trap)
— Unilateral labial swelling, dyspareunia, difficulty walking/sitting
— Acute fluctuant tender mass at 4 or 8 o'clock with overlying erythema → abscess
— Soft, nontender labial fullness noted incidentally → simple cyst
— Prior Bartholin disease (recurrence ~10–15%), sexually active reproductive-age status, trauma/episiotomy, tight clothing/poor hygiene contribute minimally
Board pearl: A new Bartholin "cyst" in a woman ≥40, particularly postmenopausal, warrants biopsy of the gland wall at the time of drainage — adenocarcinoma of the Bartholin gland is rare but the USMLE loves this distinction. In reproductive-age women, routine biopsy is not required; clinical management suffices.
Key distinction: Cyst = obstruction without infection (asymptomatic or mild). Abscess = infected, painful, fluctuant, often requires drainage. The treatment threshold is symptom-driven, not size-driven.
— 2–4 day history of progressive unilateral vulvar pain and swelling
— Worsening with sitting, walking, intercourse, tight clothing
— Subjective fever uncommon; systemic symptoms suggest deeper cellulitis or alternate diagnosis
— Spontaneous rupture with purulent drainage and immediate pain relief — patient may present after this event
— Painless or minimally uncomfortable labial fullness, often noted while bathing
— May be chronic and stable for months to years
— Becomes symptomatic only with size >3 cm, dyspareunia, or secondary infection
— Duration, laterality, prior episodes (recurrence pattern guides definitive procedure choice)
— Sexual history: new partners, dyspareunia, vaginal discharge → screen for GC/CT and HIV even though they rarely cause the abscess
— LMP and pregnancy status (alters antibiotic and procedural choices)
— Diabetes, immunosuppression, IVDU (raises MRSA risk and complication threshold)
— Postmenopausal status → malignancy workup pathway
— Allergies, prior surgeries in the area, prior marsupialization or Word catheter
— Fever, chills, rigors, spreading erythema → think cellulitis, necrotizing infection, or pelvic abscess extension
— Immunocompromise + rapid progression → low threshold for surgical consult
— Vulvar mass that is hard, fixed, ulcerated, or pigmented → biopsy, not drain
Step 3 management: In the ambulatory clinic, the encounter for suspected Bartholin abscess should include (1) confirm pregnancy status, (2) take a sexual history and order NAAT for GC/CT if risk factors, (3) assess for systemic signs, (4) plan in-office incision and drainage with Word catheter — referral to ED or GYN is needed only for failed drainage, deep extension, immunocompromise, or postmenopausal mass.
Board pearl: A patient who reports spontaneous rupture and dramatic relief still needs evaluation — incomplete drainage commonly leads to early recurrence within 1–2 weeks.
— Vital signs: most patients are afebrile and hemodynamically normal
— Fever, tachycardia, or hypotension are atypical and should prompt evaluation for cellulitis, necrotizing soft-tissue infection, sepsis, or alternative diagnosis (tubo-ovarian abscess, pelvic abscess)
— Inguinal lymphadenopathy mild and reactive in abscess; fixed, matted nodes raise malignancy concern
— Position: lithotomy with adequate lighting
— Cyst: soft, nontender or minimally tender, unilateral swelling of the posterior labia majora at 4 or 8 o'clock; introitus may be deviated; overlying skin normal
— Abscess: tender, fluctuant, warm, erythematous mass; may "point" with thinning skin and visible pus; size typically 1–8 cm
— Bilateral simultaneous Bartholin abscesses are rare — reconsider diagnosis (think hidradenitis suppurativa, Crohn vulvar disease)
— Always palpate the contralateral gland and inguinal nodes
— Perform if tolerated to assess for cervicitis, mucopurulent discharge, vaginitis, or upper tract involvement
— Cervical motion tenderness or adnexal mass → evaluate for PID/TOA, which may coexist or mimic
— In severely tender patients, defer until after drainage and analgesia
— Skene gland cyst: periurethral, anterior, near urethral meatus — wrong location
— Vulvar/labial abscess (folliculitis, hidradenitis): more superficial, often multiple, classic intertriginous sites
— Inclusion cyst, lipoma, fibroma: non-fluctuant, mobile
— Vulvar carcinoma: indurated, ulcerated, fixed; biopsy mandatory
CCS pearl: Order set on presentation: vital signs, focused GU exam, urine hCG, NAAT GC/CT if risk factors; CBC and blood cultures are not routine for an uncomplicated outpatient Bartholin abscess and ordering them would be marked as low-value care. Reserve labs for systemic illness, immunocompromise, or treatment failure.
Key distinction: Bartholin pathology is posterior/inferior at 4 or 8 o'clock; Skene pathology is anterior near the urethra. Location alone usually nails the diagnosis on the exam.
— History and inspection of the introitus are sufficient in the vast majority of reproductive-age women
— Routine labs and imaging are not indicated for uncomplicated cyst or abscess
— Resist the urge to order extensive workup — high-value Step 3 care emphasizes restraint
— Urine pregnancy test (β-hCG): essential before any procedure or antibiotic; alters analgesic, antibiotic, and anesthetic choices
— NAAT for N. gonorrhoeae and C. trachomatis from endocervix or vaginal swab — recommended given sexual transmission risk and coexistence, even though they are no longer the dominant pathogens
— Offer HIV, syphilis, and hepatitis screening per CDC for any patient presenting with a possible STI-associated condition
— Wound/abscess culture at time of drainage: increasingly recommended given rising community-acquired MRSA prevalence (15–30% in some US series); helps tailor antibiotics if empiric therapy fails
— CBC with differential, BMP, lactate, blood cultures × 2
— Glucose/HbA1c if uncontrolled diabetes suspected — recurrent or severe vulvar infections can be a presenting feature
— Reserve transperineal or pelvic ultrasound for ambiguous masses, suspected deep extension, or to distinguish from other pelvic pathology
— MRI if vulvar malignancy is suspected or anatomy is distorted by prior surgery
— CT pelvis if necrotizing soft tissue infection or pelvic extension is on the differential
— Indicated for any postmenopausal patient or any patient with an atypical, hard, fixed, or ulcerated mass
— Performed at the time of drainage; sample the gland wall, not just cyst contents
Board pearl: A common Step 3 trap is over-ordering — choosing "CT pelvis" or "CBC, BMP, blood cultures" for a well-appearing 25-year-old with a classic fluctuant 3-cm vulvar abscess is wrong. The correct answer is bedside I&D with Word catheter and selective STI testing.
Step 3 management: Always document pregnancy status and STI risk before procedure; this is both clinically and medicolegally protective.
— Postmenopausal woman with a Bartholin-area mass
— Mass that is solid, fixed, ulcerated, asymmetric, or fails to resolve after drainage
— Recurrent abscess (≥2 episodes) despite appropriate procedure
— Suspected pelvic or deep perineal extension
— Immunocompromised host with severe or atypical features
— Performed at time of marsupialization or excision
— Indicated in all women ≥40 with a new Bartholin mass, per ACOG/expert consensus, because of Bartholin gland carcinoma risk (adenocarcinoma > squamous > adenoid cystic > transitional)
— Histology guides whether referral to gynecologic oncology is needed
— Transperineal/transvaginal ultrasound: distinguishes cystic vs solid, identifies loculations, measures depth; useful when exam is equivocal
— MRI pelvis with contrast: best for soft-tissue characterization, suspected malignancy, fistula, or atypical anatomy
— CT pelvis: preferred for suspected necrotizing infection, deep abscess, or to evaluate for coexisting pelvic abscess or fistula in Crohn-associated disease
— Persistent or recurrent abscess: send aerobic, anaerobic, fungal, and AFB cultures if immunocompromised
— Consider tuberculous Bartholin disease in patients from endemic regions with chronic non-healing lesions
— Repeat NAAT after treatment if initially positive for GC/CT (test of cure for GC in pharyngeal sites or pregnancy; reinfection testing in 3 months)
— Bartholin gland carcinoma incidence rises sharply after age 40; lifetime risk ~0.1 per 100,000 but represents ~5% of vulvar malignancies
— Look for deep induration, fixation, persistent mass after drainage, or bloody discharge
Key distinction: A recurrent cyst in a young woman → consider marsupialization or excision. A recurrent cyst in a postmenopausal woman → excisional biopsy with histology, not just another I&D — this is a frequently tested Step 3 nuance.
Board pearl: "Persistent mass after drainage" in any age group warrants imaging and biopsy; do not assume incomplete drainage.
— Asymptomatic cyst, any size, premenopausal: observation, warm sitz baths, reassurance; no procedure needed
— Symptomatic cyst (pain, dyspareunia, functional impairment): drainage with Word catheter or marsupialization
— Acute abscess: incision and drainage with Word catheter placement is first-line; sitz baths alone are insufficient
— Recurrent disease (≥2 episodes): marsupialization preferred; gland excision reserved for refractory cases
— Postmenopausal mass: drainage plus biopsy; consider excision
— Can be placed in office under local anesthesia in 5–10 minutes
— Creates an epithelialized tract over 4–6 weeks → reduces recurrence vs simple I&D
— Simple I&D alone has recurrence rates up to 13–17%; Word catheter ~4–17% but with better long-term patency
— Adjunct for both cyst and post-procedure care
— Warm water 10–15 min, 3–4 times daily for several days
— Can occasionally cause spontaneous drainage of small abscesses
— Not required for uncomplicated abscess after adequate drainage in healthy patients
— Indicated if: surrounding cellulitis, systemic signs, immunocompromise, pregnancy, recurrent disease, high-risk for MRSA, or positive GC/CT
— Coverage should target skin flora and consider MRSA + anaerobes
— Needle aspiration alone — recurrence rate >70%
— Empiric long-course oral antibiotics without drainage — antibiotics do not penetrate an undrained abscess
Step 3 management: The single most-tested management point: for a fluctuant Bartholin abscess in a healthy reproductive-age woman, perform incision and drainage with Word catheter placement; antibiotics are not routinely required. Choose this answer over "broad-spectrum IV antibiotics" or "CT pelvis."
Board pearl: Reserve gland excision for multiple recurrences after marsupialization — it is morbid (bleeding, dyspareunia, scarring) and not first- or second-line.
— Drainage is the cornerstone; antibiotics are adjunctive
— Empiric coverage should target skin flora (Staph/Strep including MRSA), gut anaerobes, and gram-negatives, and add GC/CT coverage if STI suspected
— Surrounding cellulitis (erythema extending >2 cm beyond margin)
— Systemic signs (fever, leukocytosis, tachycardia)
— Immunocompromise (diabetes, HIV, chemotherapy, pregnancy)
— Recurrent abscess or failed prior drainage
— Risk factors for MRSA (prior MRSA, recent hospitalization, IVDU, household contact)
— Confirmed GC/CT
— TMP-SMX DS 1–2 tabs PO BID × 7 days PLUS amoxicillin-clavulanate 875/125 mg PO BID × 7 days
— Alternative: clindamycin 300–450 mg PO QID × 7 days (covers MRSA and anaerobes as monotherapy, but rising resistance)
— Alternative: doxycycline 100 mg PO BID × 7 days PLUS metronidazole 500 mg PO TID × 7 days
— Ceftriaxone 500 mg IM × 1 (1 g if ≥150 kg) for GC
— Doxycycline 100 mg PO BID × 7 days for CT (azithromycin 1 g PO × 1 in pregnancy)
— Expedited partner therapy per state law
— IV piperacillin-tazobactam or ampicillin-sulbactam + vancomycin if MRSA risk
— Step down to oral once clinically improved and afebrile 24–48 h
— Typically 7 days for uncomplicated outpatient cases
— Extend to 10–14 days for severe, deep, or immunocompromised cases
Board pearl: Don't forget anaerobic coverage — Bartholin abscesses are frequently polymicrobial with Bacteroides and Prevotella. Cephalexin or dicloxacillin alone miss anaerobes and are inferior choices.
Key distinction: Single-agent clindamycin covers MRSA + anaerobes but not gram-negatives well; TMP-SMX + amox-clav covers the full spectrum and is the preferred combo when MRSA is a concern.
— Setup: lithotomy, sterile prep, 1% lidocaine local infiltration over mucosal (not skin) surface of abscess
— Incision: 5 mm stab incision on the mucosal surface just inside the hymenal ring (NOT on the skin — skin incision risks fistula and visible scarring)
— Break up loculations with hemostat, send culture, irrigate
— Insert Word catheter, inflate balloon with 2–4 mL sterile saline (not air)
— Tuck free end into vagina
— Leave in place 4–6 weeks to allow epithelialization of the tract
— Patient resumes most activities; pelvic rest typically advised
— Performed under local or regional anesthesia in OR or clinic
— Elliptical incision through cyst wall, evert edges, suture cyst wall to vestibular mucosa with absorbable sutures
— Creates a permanent epithelialized opening
— Recurrence rate ~5–10%, lower than Word catheter
— Alternative office procedures; evidence varies; reasonable second-line options where available
— Reserved for failed marsupialization, recurrent disease, or suspected malignancy
— Performed in OR under regional or general anesthesia
— Risks: significant bleeding (vestibular venous plexus), hematoma, dyspareunia, scarring, nerve injury
— Always send specimen to pathology
— Sitz baths 2–3 times daily starting day 1–2
— Acetaminophen/NSAIDs for pain; opioids rarely needed
— Pelvic rest until catheter removed
— Follow-up at 1–2 weeks to assess placement and 4–6 weeks for catheter removal
CCS pearl: Order set for in-office I&D: lidocaine 1%, 11-blade scalpel, hemostat, Word catheter, 3-mL syringe with saline, culture swab, gauze, sitz bath instructions, return precautions. Skipping the Word catheter in favor of "I&D only" leads to early recurrence — a classic CCS deduction.
— New Bartholin-area mass after menopause has a disproportionate risk of malignancy
— Bartholin gland carcinoma: adenocarcinoma (40%), squamous (40%), adenoid cystic, transitional
— Management mandate: drainage + excisional biopsy of gland wall, even if mass appears benign cystic
— If malignancy confirmed → refer to gynecologic oncology for radical vulvectomy ± inguinofemoral lymphadenectomy ± adjuvant radiation
— Do not perform isolated Word catheter and discharge a postmenopausal patient without pathology
— Wound healing slower; control diabetes, optimize nutrition
— Atrophic vaginitis may complicate exam and healing — consider topical vaginal estrogen postoperatively
— Review anticoagulation; hold per procedural guidelines (e.g., warfarin INR <1.5 for excision; bridging usually unnecessary for office I&D)
— Polypharmacy: avoid NSAIDs in CKD or CHF; use acetaminophen
— TMP-SMX: dose-reduce if CrCl <30; avoid in severe hyperkalemia or AKI
— Cephalosporins/penicillins: generally dose-adjust by CrCl
— Avoid nitrofurantoin (not indicated here anyway) and minimize aminoglycosides
— Metronidazole: reduce dose in severe hepatic impairment (Child-Pugh C)
— Amox-clav: caution due to risk of cholestatic hepatitis
— Clindamycin: hepatic metabolism — monitor LFTs in severe disease
— Lower threshold to admit, broaden antibiotic spectrum, image to rule out deep extension
— Cultures essential; include fungal/AFB if atypical course
— Strict glycemic control accelerates healing
Board pearl: The single most-tested elderly Bartholin point: "55-year-old postmenopausal woman with a new 3 cm tender labial mass" → answer is excisional biopsy, not Word catheter alone.
Step 3 management: Document menopausal status, last screening exams, and any unexplained bleeding — these guide both immediate and longitudinal care.
— Bartholin cysts and abscesses occur in ~2% of pregnancies; engorgement and immune shifts increase risk
— Management is the same: drainage with Word catheter for symptomatic cyst or abscess
— Local anesthesia (lidocaine without epinephrine near term is fine) is safe
— Safe antibiotics: amoxicillin-clavulanate, cephalosporins, clindamycin, metronidazole (all trimesters — extensive data show safety despite older concerns), azithromycin
— Avoid: doxycycline (tooth/bone), TMP-SMX (avoid 1st trimester — folate antagonism, neural tube; avoid 3rd trimester — kernicterus), fluoroquinolones
— Timing of procedures: drain when symptomatic; defer elective marsupialization or excision until postpartum to avoid vascular engorgement and bleeding
— Near term: if abscess obstructs the birth canal, drain before delivery; vaginal delivery is not contraindicated by a Bartholin abscess
— Same approach as adults — Word catheter and selective STI testing
— Confidentiality: minors in most US states can consent to STI testing and treatment without parental notification; know your state law
— Address contraception and HPV vaccination opportunistically
— Bartholin glands are not yet functional → a "Bartholin cyst" in a prepubertal child is almost never truly Bartholin in origin
— Consider other diagnoses: mesonephric/Skene cyst, hemangioma, lipoma, rhabdomyosarcoma (sarcoma botryoides), abuse-related trauma
— Refer to pediatric gynecology; do not perform routine I&D without imaging and specialist input
— All recommended antibiotics (amox-clav, cephalosporins, clindamycin, metronidazole short course) are compatible with breastfeeding
— Sitz baths, pelvic rest, and standard wound care apply
Board pearl: In a prepubertal girl, a vulvar mass is never assumed to be a Bartholin cyst — pursue specialist evaluation and consider rhabdomyosarcoma on the differential.
Key distinction: Pregnancy changes antibiotic choice and timing of definitive procedures, but not the indication for drainage.
— Most common complication; rates depend on procedure
— Simple I&D alone: 13–17%
— Word catheter: 4–17%
— Marsupialization: 5–10%
— Gland excision: <5% but at cost of morbidity
— Recurrent disease should prompt re-evaluation and consideration of malignancy if age ≥40
— Erythema, warmth, induration beyond the abscess margin
— Manage with antibiotics + adequate drainage
— Watch for progression to necrotizing fasciitis — pain out of proportion, bullae, crepitus, systemic toxicity → surgical emergency, broad-spectrum IV antibiotics, OR debridement
— Rare in immunocompetent hosts; more common in diabetes, immunosuppression
— Treat per Surviving Sepsis: fluids, broad-spectrum antibiotics within 1 hour, source control
— Bleeding/hematoma: especially with excision (vestibular venous plexus); pressure, surgical hemostasis
— Word catheter dislodgement or premature expulsion → recurrence
— Fistula formation if incision made on the labial skin rather than vestibular mucosa
— Scarring, dyspareunia, vestibular pain syndromes — more common after excision
— Anesthetic complications: lidocaine toxicity if overdosed
— Rare but devastating polymicrobial necrotizing infection of the perineum/genitalia
— Risk factors: diabetes, immunosuppression, alcohol use
— Recognize early: severe pain, dusky skin, crepitus, systemic toxicity
— Immediate surgical debridement, broad-spectrum IV antibiotics, ICU
— Failure to biopsy in postmenopausal women is a recurring medicolegal pitfall
Board pearl: Pain out of proportion to exam plus systemic toxicity after a "simple" Bartholin abscess = necrotizing fasciitis until proven otherwise — call surgery now, do not wait for imaging.
Step 3 management: Document return precautions explicitly: fever, spreading redness, severe pain, dislodged catheter, or no improvement in 48–72 hours — return immediately.
— Healthy, hemodynamically stable patient with classic abscess or symptomatic cyst
— Adequate clinic resources (lidocaine, scalpel, Word catheter, follow-up capacity)
— Reliable patient with transportation and ability to perform sitz baths
— Systemic toxicity: fever >38.5°C, tachycardia, hypotension, altered mental status
— Suspected necrotizing infection (pain out of proportion, crepitus, bullae, rapid spread)
— Pelvic abscess or deep extension on exam
— Failure of office drainage or inability to perform procedure
— Severe immunocompromise
— Recurrent disease (≥2 episodes despite Word catheter) → marsupialization or excision
— Postmenopausal mass → excisional biopsy
— Pregnancy with abscess near term or complex anatomy
— Suspected malignancy → refer to gynecologic oncology
— Vulvar pain syndromes or complex perineal anatomy (prior radiation, fistula)
— Sepsis or severe cellulitis requiring IV antibiotics
— Necrotizing infection (ICU, OR)
— Poorly controlled diabetes with severe infection
— Inability to tolerate oral intake or medications
— Social barriers preventing safe outpatient management
— Septic shock requiring vasopressors
— Necrotizing fasciitis postoperatively
— Multi-organ dysfunction
— Infectious disease consult if MRSA bacteremia, atypical pathogens, or treatment failure
— Endocrinology if newly identified poorly controlled diabetes
— Social work if IVDU, housing instability, or violence concerns affect follow-up
CCS pearl: On the CCS, the screen for a hemodynamically stable patient with classic Bartholin abscess should end with "discharge home after I&D with Word catheter, oral antibiotics if indicated, sitz baths, return precautions, and follow-up in 1–2 weeks." Admitting a well patient for IV antibiotics is a deduction.
Board pearl: Hemodynamic instability + vulvar infection = necrotizing fasciitis until proven otherwise, regardless of how the abscess looked initially.
— Periurethral, anterior to vaginal introitus, near urethral meatus
— May cause dysuria, urinary retention, urethral discharge
— Management similar: I&D, marsupialization; rule out gonorrhea
— Key distinguishing feature: location
— Superficial, often multiple, scattered on labia majora
— Slow-growing, may have central punctum; minimally tender unless infected
— Excision or observation; do not require Word catheter
— Chronic, recurrent, painful multiple abscesses, sinus tracts, scarring in intertriginous areas (axilla, groin, vulva, perineum)
— Apocrine gland-bearing skin involvement
— Treatment is medical (topical/oral clindamycin, adalimumab, hormonal modulation) plus surgical for refractory disease
— Key distinction: multifocal and chronic vs solitary, located classically at 4/8 o'clock
— Hair follicle infection, often S. aureus including MRSA
— More superficial, multiple, on labia majora rather than at duct orifice
— Warm compresses ± I&D ± antibiotics
— History suggests etiology; manage as polymicrobial soft-tissue infection
— Painful vesicles or ulcers, not a fluctuant mass
— Tender inguinal lymphadenopathy, often bilateral
— PCR or viral culture; antiviral therapy (acyclovir, valacyclovir)
— Solid, fixed, ulcerated, indurated; postmenopausal women
— Biopsy is diagnostic; refer to gyn-onc
— Cyclic pain, bluish discoloration; rare but on differential for non-classic masses
Key distinction: Location, multiplicity, and chronicity sort these out. Solitary, 4 or 8 o'clock, acute = Bartholin. Multiple, chronic, intertriginous = hidradenitis. Anterior, periurethral = Skene.
Board pearl: A vulvar ulcer is not a Bartholin abscess — think HSV, syphilis (painless chancre), chancroid (painful with ragged edges), or malignancy.
— Lower abdominal pain, cervical motion tenderness, adnexal mass
— May coexist with Bartholin disease (shared STI risk factors)
— Diagnostic: pelvic exam, NAAT, transvaginal ultrasound, CT pelvis
— Treatment: IV ceftriaxone + doxycycline + metronidazole (CDC 2021 regimen)
— Fistulizing perianal/vulvar disease, "knife-cut" linear ulcers, edematous labia, recurrent abscesses unresponsive to standard care
— Often misdiagnosed initially as recurrent Bartholin abscess
— Diagnostic: GI history, colonoscopy, MRI pelvis, biopsy showing non-caseating granulomas
— Treatment: anti-TNF (infliximab, adalimumab), surgical drainage, multidisciplinary care
— Recurrent abscesses in young patient → screen for HIV, diabetes, leukemia
— Atypical organisms possible
— Lymphogranuloma venereum (C. trachomatis L1–L3): inguinal buboes, may rupture; doxycycline 21 days
— Chancroid (H. ducreyi): painful ulcer + tender lymphadenopathy; azithromycin or ceftriaxone
— Granuloma inguinale (Klebsiella granulomatis): painless beefy red ulcer; azithromycin
— Necrotizing fasciitis of perineum/genitalia
— Diabetic, immunocompromised men > women but possible in either
— Pain out of proportion, crepitus, rapid spread
— Emergent debridement + broad-spectrum IV antibiotics
— Ovarian cysts, ectopic pregnancy can refer pain to vulva but lack local fluctuance
— Always check β-hCG in reproductive-age women with pelvic symptoms
— Anterior vaginal wall mass, post-void dribbling, dyspareunia, recurrent UTI
— MRI diagnostic
Board pearl: Recurrent vulvar abscesses unresponsive to standard care in a young woman = think Crohn disease. Order colonoscopy and pelvic MRI; this is a classic Step 3 vignette trap.
Key distinction: Coexistence matters — a Bartholin abscess + cervical motion tenderness + adnexal mass = PID/TOA layered on, requiring broader treatment.
— Oral antibiotic (if indicated) — e.g., TMP-SMX DS BID + amox-clav 875 BID × 7 days, or clindamycin 300 mg QID × 7 days
— Acetaminophen 650–1000 mg q6h PRN and/or ibuprofen 400–600 mg q6h PRN (avoid NSAIDs in CKD or peptic ulcer disease)
— Avoid routine opioid prescription — most patients control pain with NSAIDs/APAP after drainage; aligns with safe opioid stewardship
— Stool softener if opioid prescribed
— Topical vaginal estrogen if postmenopausal and tissues atrophic
— Warm water, 10–15 minutes, 2–4 times daily for 5–7 days
— Promotes drainage, hygiene, and comfort
— No additives needed; plain water sufficient
— Loose-fitting cotton underwear, avoid tight clothing during recovery
— Pelvic rest (no intercourse, tampons, douching) until catheter removed and area healed
— Smoking cessation — improves wound healing and reduces hidradenitis-spectrum disease
— Glycemic optimization if diabetic — HbA1c <7% target
— Treat partners if GC/CT positive (expedited partner therapy where legal)
— Reinforce condom use
— Routine STI rescreening at 3 months if GC/CT positive (high reinfection rate)
— Offer HIV PrEP if ongoing risk
— Word catheter retention 4–6 weeks for epithelialization
— Discuss marsupialization if recurrence occurs
— Vaccination: ensure HPV vaccination up to age 45 if eligible
— Postmenopausal patients: yearly vulvar exam after Bartholin biopsy regardless of pathology
— Reproductive-age: routine well-woman care; no special surveillance after single resolved episode
Step 3 management: At discharge, every patient leaves with: (1) clear instructions on catheter care, (2) sitz bath instructions, (3) return precautions, (4) follow-up appointment scheduled, (5) STI results plan, (6) appropriate analgesia without unnecessary opioids.
Board pearl: Opioid-sparing analgesia is the Step 3-favored answer for post-procedural pain in this and most outpatient surgical scenarios.
— 1–2 weeks post-procedure: assess Word catheter position, wound healing, symptom resolution, review culture and NAAT results
— 4–6 weeks: remove Word catheter in office (deflate balloon, gentle traction); inspect for patent stoma
— 3 months: if GC/CT was positive, retest for reinfection per CDC guidance
— Annual well-woman exam: include focused vulvar inspection in patients with prior Bartholin disease
— Resolution of pain, erythema, fluctuance
— Catheter retention; patient-reported dislodgement triggers re-evaluation
— New mass, induration, or persistent drainage → reassess for incomplete treatment or malignancy
— Glycemic control in diabetics
— Mental health and sexual function — vulvar procedures can impact intimacy
— Reassurance: Bartholin disease is common, not associated with poor hygiene or STIs in most cases
— Recurrence rates and the role of marsupialization if it happens again
— Postmenopausal patients: explain the importance of biopsy and that pathology results drive next steps
— Sexual activity can resume after catheter removal and complete healing, typically 4–6 weeks
— Discuss expected appearance — a small residual stoma or asymmetry is normal after marsupialization
— Return immediately for: fever, spreading erythema, severe pain, catheter dislodgement before 4 weeks, foul drainage, bleeding
— Document teach-back of warning signs
— Avoid unnecessary imaging and labs in straightforward cases
— Use evidence-based antibiotic stewardship (no antibiotics for uncomplicated drained abscess)
— Document shared decision-making, especially for marsupialization vs Word catheter
Board pearl: Many Bartholin abscesses resolve clinically before culture results return — but always close the loop on GC/CT NAAT and treat positives, even if the patient is asymptomatic. This is both a clinical and a public health responsibility.
Step 3 management: The "ideal" outpatient course: I&D + Word catheter → check at 1–2 weeks → catheter removed at 4–6 weeks → STI retest at 3 months if applicable → return to routine care.
— Discuss alternatives (observation, sitz baths, marsupialization, excision), risks (bleeding, infection, recurrence, scarring, dyspareunia, fistula), and benefits before I&D and Word catheter
— Document consent in the chart; verbal consent is acceptable for office I&D in most jurisdictions but written consent is preferred
— Capacity assessment: routine for adults; for adolescents, see below
— Most US states permit minors to consent independently to STI testing, treatment, and contraception without parental notification
— Confidentiality of EMR billing and labs can inadvertently breach privacy — counsel teens about how results may appear on insurance statements
— When parental consent is required for procedure, navigate carefully with patient input
— Suspected sexual abuse or assault in any patient → report per state law (children always; adults vary)
— Vulvar injuries inconsistent with stated history warrant social work and possibly law enforcement involvement
— Offer SART/forensic exam if assault is recent (within 72–120 hours typically) — do not perform I&D before forensic collection if assault is suspected and timeframe allows
— Closed-loop communication of NAAT results — a positive GC/CT result that goes unreported is a major safety failure
— Ensure follow-up appointment is scheduled before discharge, not "patient will call"
— Provide written discharge instructions in the patient's preferred language; use professional interpreters, not family members
— Avoid unnecessary antibiotics — C. difficile risk, resistance, allergy
— Document allergy histories accurately; "rash with penicillin as a child" should not automatically eliminate beta-lactams without clarification
— Universal protocol: site marking is generally not required for office I&D but laterality should be confirmed and documented
— Use sterile technique; sharps safety; appropriate sharps disposal
— Lidocaine dosing: max 4.5 mg/kg plain (max ~300 mg adult); document amount used
— Bartholin disease disproportionately presents to safety-net settings; ensure access to follow-up regardless of insurance status
Step 3 management: A 16-year-old presents alone with a Bartholin abscess. Correct answer: provide confidential care, perform I&D with consent, test for STIs, and counsel — parental notification is not required for STI-related care in most states.
Board pearl: Failing to communicate a positive STI result and arrange treatment is a leading malpractice and public-health failure point.
Board pearl: If the vignette mentions a woman ≥40 with a "new Bartholin cyst," the answer almost always involves biopsy or excision, not Word catheter alone.
Key distinction: "Cyst" = obstruction without infection; "abscess" = infected, fluctuant, tender, drainable.
— 26-year-old woman with 3 days of unilateral vulvar pain, fluctuant 4-cm mass at 5 o'clock, afebrile, stable
— Best next step: I&D with Word catheter placement; selective NAAT GC/CT
— Distractors: broad-spectrum IV antibiotics, CT pelvis, gland excision, oral antibiotics alone
— 58-year-old postmenopausal woman with new 2-cm tender vulvar mass at 8 o'clock
— Best next step: drainage plus excisional biopsy of gland wall
— Distractors: Word catheter alone, observation, antibiotics alone
— 28-year-old G2P1 at 32 weeks with painful Bartholin abscess
— Best next step: in-office I&D with Word catheter under local anesthesia + pregnancy-safe antibiotic if cellulitis (amox-clav or clindamycin)
— Distractors: defer until postpartum, doxycycline, TMP-SMX
— 32-year-old with third Bartholin abscess in 18 months, prior I&D each time
— Best next step: marsupialization
— Distractors: another I&D + Word catheter, long-term suppressive antibiotics, gland excision (premature)
— 24-year-old with recurrent vulvar abscesses, chronic diarrhea, weight loss, perianal fistula
— Best next step: colonoscopy + GI referral; consider anti-TNF therapy
— Distractor: repeat I&D
— 55-year-old diabetic with Bartholin abscess + severe pain, dusky skin, crepitus, fever, hypotension
— Best next step: emergent surgical debridement + broad-spectrum IV antibiotics + ICU
— Distractor: office I&D, outpatient antibiotics
— 15-year-old presents alone with vulvar abscess, asks not to inform parents
— Best next step: provide confidential care, perform I&D, test for STIs
— Distractor: defer until parental consent obtained
— 6-year-old with a vulvar mass
— Best next step: pediatric gynecology referral, imaging; consider rhabdomyosarcoma
— Distractor: routine I&D
— Patient drained 1 week ago, NAAT now positive for GC
— Best next step: treat with ceftriaxone 500 mg IM, treat for chlamydia presumptively with doxycycline, expedited partner therapy, retest at 3 months
Step 3 management: Recognize the stem's pivot — age, recurrence, systemic signs, pregnancy, immunocompromise — these features determine which "best next step" wins.
Board pearl: When in doubt on a Bartholin question and the patient is healthy and premenopausal, the answer is usually I&D with Word catheter — not antibiotics, imaging, or excision.
For a symptomatic Bartholin cyst or abscess in a healthy reproductive-age woman, the answer is bedside incision and drainage with Word catheter placement through a mucosal-side incision, retained 4–6 weeks, with antibiotics reserved for cellulitis, systemic illness, immunocompromise, MRSA risk, pregnancy, recurrence, or confirmed GC/CT — and biopsy of the gland wall mandatory in any woman ≥40 to rule out Bartholin gland carcinoma.
— First-line procedure: I&D + Word catheter for abscess or symptomatic cyst; marsupialization for recurrent disease; gland excision only as a last resort
— Antibiotics: not routine; when needed, cover skin flora + MRSA + anaerobes (e.g., TMP-SMX + amox-clav, or clindamycin); add ceftriaxone + doxycycline if GC/CT
— Always biopsy a Bartholin-area mass in women ≥40 or with atypical features (fixed, indurated, ulcerated, persistent after drainage)
— Pregnancy: same drainage approach; use pregnancy-safe antibiotics (amox-clav, cephalosporins, clindamycin, metronidazole); defer elective excision until postpartum
— Prepubertal child: not a true Bartholin cyst — refer and rule out rhabdomyosarcoma
— Necrotizing infection (pain out of proportion, crepitus, systemic toxicity) → emergent surgery + broad-spectrum IV antibiotics + ICU
— Follow-up: 1–2 weeks (catheter check), 4–6 weeks (catheter removal), 3 months (STI retest if applicable)
— Counseling: sitz baths, pelvic rest until healing, opioid-sparing analgesia, STI partner notification, confidentiality protections for adolescents
Board pearl: The three most-tested pivots are (1) age ≥40 → biopsy, (2) recurrent → marsupialization, and (3) systemic toxicity → think necrotizing fasciitis. Master these and most Bartholin questions become straightforward.
Step 3 management: Deliver definitive care in the ambulatory setting, close the loop on STI results, schedule explicit follow-up, and avoid over-treatment with antibiotics or unnecessary imaging — this is high-value, guideline-concordant care.